Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study

BACKGROUND: Treating pneumonia in old patients remains challenging for clinicians. Moreover, bacterial antimicrobial resistance is a major public health threat. OBJECTIVE: The PROPAGE study evaluated the interest of a strategy using serial measurements of procalcitonin (PCT) to reduce the duration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavazzi, Gaëtan, Drevet, Sabine, Debray, Matthieu, Bosson, Jean Luc, Tidadini, Fatah, Paccalin, Marc, de Wazieres, Benoit, Celarier, Thomas, Bonnefoy, Marc, Vitrat, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748380/
https://www.ncbi.nlm.nih.gov/pubmed/36517740
http://dx.doi.org/10.1186/s12877-022-03658-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748380/
https://www.ncbi.nlm.nih.gov/pubmed/36517740
http://dx.doi.org/10.1186/s12877-022-03658-4

Ejemplares similares